Home/ Stocks/ SBFM

Sunshine Biopharma Inc.

SBFM XNAS

$1.00 +0.02 (+1.96%) ▲ 15-min delayed

Open

$1.00

High

$1.02

Low

$1.00

Volume

31.0K

Market Cap

$5.00M

About Sunshine Biopharma Inc.

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 52 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$9.42M	$-883,820	$-0.19
Q2 2025	$9.41M	$-1,770,834	$-0.39
Q1 2025	$8.90M	$-1,179,771	$-0.44
FY 2024	$34.87M	$-5,134,116	$-7.32

Earnings & Analyst Ratings

Next Earnings: Wed, May 13, 2026

Calendar →

Related Market News

No specific coverage for SBFM yet. Check out our latest market news or earnings calendar.

Get SBFM Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Sunshine Biopharma Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.